Limits of commercial molecular tests for diagnosis of pulmonary tuberculosis

Several studies report high specificity, but variable sensitivity, of Amplified Mycobacterium tuberculosis Direct Test (AMTDT, Gen-Probe) based on ribosomal ribonucleic acid (rRNA) amplification and Amplicor Mycobacterium tuberculosis test (Amplicor, Roche) based on deoxyribonucleic acid (DNA) amplification for diagnosis of pulmonary tuberculosis. We have retrospectively evaluated these assays on selected acid-fast bacilli (AFB)-positive and -negative smear specimens and compared the results obtained from nucleic acid amplification with those of AFB staining of semi-quantitative cultures as determined by radiometric Bactec and Lowenstein-Jensen cultures. In comparison to cultures, Amplicor and AMTDT assays exhibited identical overall sensitivities of 80%, while the staining had a lower sensitivity of 62%. The sensitivities of Amplicor and AMTDT were 98% and 100%, respectively, for the AFB-positive specimens, and 50 and 46%, respectively for the AFB-negative specimens in comparison to cultures. The sensitivities of both assays appeared similar, and were directly related to the number of bacilli in the specimens studied. The low sensitivity (50%) for smear-negative specimens showed that current amplification assays may be unsuitable to replace cultures for diagnosis of tuberculosis. The decision to perform these molecular techniques should result from close co-operation between clinicians and microbiologists, taking into account the sensitivity results reported here, as well as the expense of the assays.

This article has been cited by other articles:

				S Greco, E Girardi, A Navarra, and C Saltini Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis Thorax, September 1, 2006; 61(9): 783 - 790. [Abstract] [Full Text] [PDF]

				M. Patnaik, K. Liegmann, and J. B. Peter Rapid Detection of Smear-Negative Mycobacterium tuberculosis by PCR and Sequencing for Rifampin Resistance with DNA Extracted Directly from Slides J. Clin. Microbiol., January 1, 2001; 39(1): 51 - 52. [Abstract] [Full Text]

				T. K. Lim, A. Gough, N.-K. Chin, and G. Kumarasinghe Relationship Between Estimated Pretest Probability and Accuracy of Automated Mycobacterium tuberculosis Assay in Smear-Negative Pulmonary Tuberculosis Chest, September 1, 2000; 118(3): 641 - 647. [Abstract] [Full Text] [PDF]

				M. Gallina, P. Troupioti, G. Rocco, G. Sensalari, and E. Libanori Predicting Culture Results for Mycobacterium Tuberculosis Complex : Amplified Mycobacterium Tuberculosis Direct Test and Acid-Fast Bacilli Microscopy Chest, July 1, 2000; 118(1): 28 - 32. [Abstract] [Full Text] [PDF]

				A. García-Quintanilla, L. Garcia, G. Tudó, M. Navarro, J. González, and M. T. Jiménez de Anta Single-Tube Balanced Heminested PCR for Detecting Mycobacterium tuberculosis in Smear-Negative Samples J. Clin. Microbiol., March 1, 2000; 38(3): 1166 - 1169. [Abstract] [Full Text]

				B. Ninet, P. Rohner, C. Metral, and R. Auckenthaler Assessment of Use of the COBAS AMPLICOR System with BACTEC 12B Cultures for Rapid Detection of Frequently Identified Mycobacteria J. Clin. Microbiol., March 1, 1999; 37(3): 782 - 784. [Abstract] [Full Text]

				S. A. Watterson, S. M. Wilson, M. D. Yates, and F. A. Drobniewski Comparison of Three Molecular Assays for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis J. Clin. Microbiol., July 1, 1998; 36(7): 1969 - 1973. [Abstract] [Full Text]